JP Patent

JP7532021B2 — ムスカリン性受容体活性化によって改善される疾患の治療のための方法および組成物

Assigned to ピュアテックヘルスエルエルシー · Expires 2024-08-13 · 2y expired

What this patent protects

Patent listed against null.

Drugs covered by this patent

Patent Metadata

Patent number: JP7532021B2
Jurisdiction: JP
Classification: —
Expires: 2024-08-13
Drug substance claim: No
Drug product claim: No
Assignee: ピュアテックヘルスエルエルシー
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.